Evidence map›Paper›PMID 23542919›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2013

Arcuate nucleus injection of an anti-insulin affibody prevents the sympathetic response to insulin.

Brittany S Luckett, Jennifer L Frielle, Lawrence Wolfgang, Sean D Stocker

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Role of the carotid chemoreceptors in insulin-mediated sympathoexcitation in humans.American journal of physiology. Regulatory, integrative and comparative physiology · 2020
    Trial
  3. Article
  4. Review
  5. Sympathetic transduction to blood pressure during euglycemic-hyperinsulinemia in young healthy adults: role of burst amplitude.American journal of physiology. Regulatory, integrative and comparative physiology · 2023
    Article
  6. Review
  7. Role of the arterial baroreflex in the sympathetic response to hyperinsulinemia in adult humans.American journal of physiology. Endocrinology and metabolism · 2022
    Article
  8. Review
  9. Review
  10. Article
  11. Neuronal Networks in Hypertension: Recent Advances.Hypertension (Dallas, Tex. : 1979) · 2020
    Review
  12. Article
  13. Review
  14. Review
  15. Obesity: sex and sympathetics.Biology of sex differences · 2020
    Review
  16. Sites and sources of sympathoexcitation in obese male rats: role of brain insulin.American journal of physiology. Regulatory, integrative and comparative physiology · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Brittany S LuckettDepartment of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
Jennifer L Frielle
Lawrence Wolfgang
Sean D Stocker
Pennsylvania State University · US

Funding

Central Nervous System Mechanisms of Obesity HypertensionR01HL090826 · NHLBI · UNIVERSITY OF KENTUCKY · PI STOCKER, SEAN D · 2008 to 2012
$1.9M
Central Osmosensory Mechanisms in Salt-Sensitive HypertensionR01HL113270 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STOCKER, SEAN D · 2013 to 2016
$1.5M
NHLBI NIH HHS R01 HL090826NHLBI NIH HHS R01-HL-090826NHLBI NIH HHS R01 HL113270
6 · The paper itself

Abstract

Accumulating evidence suggests that insulin acts within the hypothalamus to alter sympathetic nerve activity (SNA) and baroreflex function. Although insulin receptors are widely expressed across the hypothalamus, recent evidence suggests that neurons of the arcuate nucleus (ARC) play an important role in the sympathoexcitatory response to insulin. The purpose of the present study was to determine whether circulating insulin acts directly in the ARC to elevate SNA. In anesthetized male Sprague-Dawley rats (275-425 g), the action of insulin was neutralized by microinjection of an anti-insulin affibody (1 ng/40 nl). To verify the efficacy of the affibody, ARC pretreatment with injection of the anti-insulin affibody completely prevented the increase in lumbar SNA produced by ARC injection of insulin. Next, ARC pretreatment with the anti-insulin affibody attenuated the lumbar sympathoexcitatory response to intracerebroventricular injection of insulin. Third, a hyperinsulinemic-euglycemic clamp increased lumbar, but not renal, SNA in animals that received ARC injection of a control affibody. However, this sympathoexcitatory response was absent in animals pretreated with the anti-insulin affibody in the ARC. Injection of the anti-insulin affibody in the adjacent ventromedial hypothalamus did not alter the sympathoexcitatory response to insulin. The ability of the anti-insulin affibody to prevent the sympathetic effects of insulin cannot be attributed to a general inactivation or nonspecific effect on ARC neurons as the affibody did not alter the sympathoexcitatory response to ARC disinhibition by gabazine. Collectively, these findings suggest that circulating insulin acts within the ARC to increase SNA.

Indexed as

AdipocytesAnimalsAntibodies, BlockingArcuate Nucleus of HypothalamusData Interpretation, StatisticalGABA AntagonistsGlucose Clamp TechniqueHyperinsulinismInjections, IntraventricularInsulinInsulin AntagonistsMaleMicroinjectionsOncogene Protein v-aktPhosphorylationPyridazinesAntibodies, BlockingGABA AntagonistsgabazineInsulinInsulin AntagonistsOncogene Protein v-aktPyridazinesblood pressurelumbarobesityrenalsympathetic nerve activity

Identifiers

PMID23542919
PMCPMC3680721
OpenAlexW2169511109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.